Estrovera® 30 Tablets | Metagenics

$34.95

  • 30 Tablets: Menopausal Hot Flash Relief*
  • Servings Per Container: 30
Category:

Serving Size: 1 Tablet

 

IngredientAmountDaily Value
Rhapontic Rhubarb (Rheum rhaponticum L.) Root† Extract (ERr 731®) [Providing 2.2 mg rhaponticin and 1 mg desoxyrhaponticin]4 mg*

 

 

Other Ingredients: Microcrystalline cellulose, stearic acid (vegetable), croscarmellose sodium, silica, and enteric coating (ethyl cellulose, ammonium hydroxide, hydroxypropylmethylcellulose, hydroxypropylcellulose, medium chain triglycerides , sodium alginate, oleic acid, and stearic acid).

Directions: Take one tablet with food and a glass of water once daily at the same time of day or as directed by your healthcare practitioner.

This product is non-GMO, gluten free, and vegetarian.

Caution: Do not use if pregnant or nursing. This product is contraindicated for individuals with any known or suspected estrogen-dependent cancer. If taking medication, consult your healthcare practitioner before use.

Storage: Keep tightly closed in a cool, dry place.

*Daily Value not established.

†Also known as Siberian rhubarb root.

 

Description

Estrovera® 30 Tablets Overview

Estrovera® featuring ERr 731®, has been used safely and effectively for over 20 years and is supported by clinical studies. Estrovera provides relief for multiple menopausal symptoms, including hot flashes, sleep disturbances, mood swings, irritability, anxiety, and sexual problems.*

Non-hormonal menopausal symptom relief*

Estrovera is a plant-based option that features ERr 731®, a special extract of Siberian rhubarb, demonstrated in clinical studies to significantly reduce menopausal symptoms—offering an effective and safe option for both peri-and postmenopausal women.*

Effective Relief for Menopausal Symptoms*
Clinically shown to dramatically reduce the number of daily hot flashes and relieve a wide range of other symptoms.*

Unprecedented Scientific Validation*
Multiple short- and long-term studies with over 400 peri-and postmenopausal women—published in peer-reviewed journals—confirm efficacy and predicted safety.*

Favorable Safety Profile
ERr 731® has been recommended by healthcare professionals in Europe since 1993.

Reviews

There are no reviews yet.

Be the first to review “Estrovera® 30 Tablets | Metagenics”

Your email address will not be published. Required fields are marked *